Raymond J R, Kim J, Beach R E, Tisher C C
Department of Medicine, Duke University Medical Center, Durham 27710.
Am J Physiol. 1993 Jan;264(1 Pt 2):F9-19. doi: 10.1152/ajprenal.1993.264.1.F9.
Northern blotting studies have demonstrated mRNA for the serotonin 5-HT1A receptor in human neonatal kidney (B. K. Kobilka, T. Frielle, S. Collins, T. Yang-Feng, T. S. Kobilka, U. Francke, R. J. Lefkowitz, and M. G. Caron. Nature Lond. 329: 75-79, 1987). To confirm expression of receptor protein in kidney, we raised antibodies to two peptides derived from the third intracellular loop of the human 5-HT1A receptor. Specific immunoglobulin G (IgG) was purified sequentially on protein A-Sepharose and peptide-Affigel 10 columns. Each IgG was able to: 1) quantitatively immunoprecipitate [3H]8-OH-2-(di-n-propylamino)1,2,3,4-tetrahydronaphthalene ([3H]8-OH-DPAT)-labeled human and rat receptors; 2) immunoblot a new protein in cells transfected with human 5-HT1A receptor DNA; and 3) immunoautoradiographically label areas of rat brain (frontal cortex, hippocampus, and lateral septum) in a highly characteristic pattern similar to that labeled by 125I-Bolton-Hunter-8-methoxy-2-(N-propyl-N-propylamino)Tetralin, a specific 5-HT1A receptor autoradiography ligand. By use of a light microscopic immunoperoxidase labeling technique, incubation of each IgG antibody with sections of rat and human kidney demonstrated an identical pattern of immunoreactivity. Specific labeling of basolateral plasma membranes was detected throughout medullary and cortical thick ascending limbs (TAL), in distal convoluted tubules (DCT), in connecting tubule cells of the connecting tubule, and in principal cells of the initial collecting tubule. There was no labeling in the inner medulla, glomeruli, or blood vessels. The labeling was blocked by preincubation with the corresponding peptide, but not with noncorresponding peptide or carrier protein. There was no labeling with preimmune IgG. Electron microscopic immunoperoxidase labeling confirmed the specific localization of the IgG antibody along the basolateral plasma membrane in all positively staining cells in rat kidney. Radioligand binding studies with the specific 5-HT1A receptor ligand [3H]8-OH-DPAT confirmed the presence of 5-HT1A receptor binding sites in bulk-isolated rat medullary TAL. These studies provide the first evidence that the 5-HT1A receptor is expressed on the basolateral surface of TAL and DCT cells of human and rat kidney. The specific localization to these cells suggests a possible role for the 5-HT1A receptor in the regulation of salt and water transport in mammalian kidney.
Northern印迹研究已证实在人类新生儿肾脏中存在5-羟色胺5-HT1A受体的信使核糖核酸(B.K.科比尔卡、T.弗里尔、S.柯林斯、T.杨-冯、T.S.科比尔卡、U.弗兰克、R.J.莱夫科维茨和M.G.卡隆。《自然》伦敦版329:75 - 79,1987年)。为了证实该受体蛋白在肾脏中的表达,我们制备了针对源自人类5-HT1A受体第三细胞内环的两种肽段的抗体。特异性免疫球蛋白G(IgG)先后在蛋白A - 琼脂糖和肽 - 亲和凝胶10柱上进行纯化。每种IgG都能够:1)定量免疫沉淀[3H]8 - 羟基 - 2 - (二正丙基氨基)-1,2,3,4 - 四氢萘([3H]8 - OH - DPAT)标记的人类和大鼠受体;2)对转染了人类5-HT1A受体DNA的细胞中的一种新蛋白质进行免疫印迹;3)以与特异性5-HT1A受体放射自显影配体125I - 博尔顿 - 亨特 - 8 - 甲氧基 - 2 - (N - 丙基 - N - 丙基氨基)四氢萘标记的高度特征性模式相似的方式,对大鼠脑(额叶皮质、海马体和外侧隔区)区域进行免疫放射自显影标记。通过使用光学显微镜免疫过氧化物酶标记技术,将每种IgG抗体与大鼠和人类肾脏切片孵育,显示出相同的免疫反应模式。在整个髓质和皮质厚升支(TAL)、远曲小管(DCT)、连接小管的连接小管细胞以及初始集合小管的主细胞中检测到基底外侧质膜的特异性标记。在内髓质、肾小球或血管中未发现标记。该标记可被与相应肽段预孵育阻断,但不能被不相应的肽段或载体蛋白阻断。用免疫前IgG未发现标记。电子显微镜免疫过氧化物酶标记证实了IgG抗体在大鼠肾脏中所有阳性染色细胞的基底外侧质膜上的特异性定位。用特异性5-HT1A受体配体[3H]8 - OH - DPAT进行的放射性配体结合研究证实了在大量分离的大鼠髓质TAL中存在5-HT1A受体结合位点。这些研究提供了首个证据,表明5-HT1A受体在人类和大鼠肾脏的TAL和DCT细胞的基底外侧表面表达。该受体在这些细胞中的特异性定位表明其在哺乳动物肾脏盐和水转运调节中可能发挥作用。